期刊文献+

神经激肽1受体拮抗剂研究进展 被引量:6

Neurokinin-1 receptor antagonists:research advances
下载PDF
导出
摘要 神经激肽中P物质是中枢神经系统最重要的神经递质之一,通过与其受体,如神经激肽1受体(NK1R)结合在多种疾病的病理过程中发挥作用。NK1R拮抗剂近年来在临床上应用广泛,不仅能够缓解抑郁、焦虑的症状,而且对抑郁症、焦虑症和化疗引起的恶心、呕吐具有很好的疗效。本文就近年来NK1R拮抗剂的研究进展进行综述。 Substance P is one of the most important neurotransmitter in the nervous system. It plays an important role in the pathological process of many diseases through combineing with its receptors,for example,neurokinin-1 receptor (NK1R). The antagonists of NK1R(NK1RA) that are widely used in recent clinical treatments can not only relieve deppression and anxiety,but also have good antiemetic effects on chemotherapy-induced nausea and vomiting. In this review,the relevant study results in this field in recent years are described.
出处 《国际药学研究杂志》 CAS 2010年第3期203-208,共6页 Journal of International Pharmaceutical Research
关键词 神经激肽 神经激肽1受体 神经激肽1受体拮抗剂 抑郁 焦虑 neurokin in neurokinin-1 receptor neurokinin-1 receptor antagonists deppression anxiety
  • 相关文献

参考文献34

  • 1Quartara L, Maggi CA. The tachykinin NK1 receptor. Part II : Distribution and pathophysiological roles [ J ]. Neuropeptides, 1998, 32(1) :1-49.
  • 2Quartara L, Maggi CA. The tachykinin NK1 receptor. Part I : Ligands and mechanisms of cellular activation [ J ]. Neuropeptides, 1997, 31(6) : 537-563.
  • 3Seto S, Tanioka A, Ikeda M, et al. Design and synthesis of novel 9-substituted-7-aryl-3,4,5,6-tetrahydro-2 H-pyrido [ 4,3-b ] - and [ 2,3-b ]-1,5-oxazocin-6-ones as NK1 antagonists [ J ]. Bioorg Med Chem Lett, 2005, 15 (5) : 1479-1484.
  • 4Harrison T, Owens AP, Williams BJ, et al. An orally active, water-soluble neumkinin-1 receptor antagonist suitable for both intravenous and oral clinical administration [ J ]. J Med Chem, 2001,44(24) :4296-4299.
  • 5Buccafusco JJ, Shuster LC. Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms [ J ]. Brain Res Bull, 1997, 43(3) :321 -326.
  • 6McCarsona KE, Krausea JE, McLean S. Chronic non-peptide neurokinin receptor antagonist treatment alters striatal tachykinin peptide and receptor gene expression in the rat [ J ]. Neurosci Lett, 1998, 251(2) :113-116.
  • 7Bender D, Olsena AK, Marthi MK, et al. PET evaluation of the uptake of N-[^ 11C] methyl CP-643,051, an NK1 receptor antago- nist, in the living porcine brain[J]. Nucl Med Biol, 2004,31 (6) :699-704.
  • 8Haddjeri N, Blier P. Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions [ J ]. Eur J Pharmacol, 2008,600 (1-3) :64-70.
  • 9Lejeune F, Gobert A, Millan MJ. The selective neurokinin (NK1) antagonist, GR205171, stereospecificically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electmphysiologieal study [ J ]. Brain Res, 2001 , 935 ( 1/2 ) : 134-139.
  • 10Worsley MA, Clayton NM, Bountra C, et al. The effects of ibuprofen and the neurokinin-1 receptor antagonist GR205171A on Fos expression in the ferret trigeminal nucleus following tooth pulp stimulation [ J ]. Eur J Pain, 2008, 12 ( 3 ) : 385-394.

同被引文献60

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部